Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(4)

DRUG(2)

denintuzumab mafodotin

6 unique interventions2 categories

Analytics

Trial Phases

Phase 11

Phase 21

Trial Status

Terminated2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT02702141Phase 1Terminated

A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma

Diffuse Large B-cell LymphomaDLBCLGrade 3 Follicular Lymphoma+1 more

StudydirectorStart date: 2016-02-01

NCT02592876Phase 2Terminated

Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma

Follicular Lymphoma, Grade 3bLymphoma, B-cellLymphoma, Follicular, Grade 3b+1 more

StudydirectorStart date: 2015-10-01

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Lymphoma, Large B-Cell, Diffuse2 DLBCL1 Follicular Lymphoma, Grade 3b1 Grade 3 Follicular Lymphoma1 Lymphoma, B-Cell1 Lymphoma, Follicular, Grade 3b1 Lymphoma, Non-Hodgkin1

Affiliations

Seagen Inc.

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

24 trials

Shared therapeutic areas:

Lymphoma, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin

Similarity Score13%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

17 trials

Shared therapeutic areas:

Lymphoma, B-CellLymphoma, Large B-Cell, Diffuse

Similarity Score9%

Roberto Hernández Martín, MD

Hospital Virgen de la Concha

2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin

Similarity Score9%

Elena Pérez Ceballos, MD

Hospital Morales Meseguer

2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin

Similarity Score9%

Yifan Zhai, MD, PhD

Ascentage Pharma Group Inc.

14 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLymphoma, B-Cell

Similarity Score9%

Carlos Montalbán Sanz, MD

Hospital Universitario Ramon y Cajal

2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin

Similarity Score9%

Eulogio Conde García, MD

Hospital Marqués de Valdecilla

2 trials

Shared therapeutic areas:

Lymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin

Similarity Score9%

David Cunningham

Royal Marsden NHS Foundation Trust

13 trials

Shared therapeutic areas:

Lymphoma, B-CellLymphoma, Non-Hodgkin

Similarity Score9%

Arnon Nagler, MD

Chaim Sheba Medical Center

12 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLymphoma, Large B-Cell, Diffuse

Similarity Score9%

Weidong Han, Ph.D

Biotherapeutic Department, Chinese PLA General Hospital

12 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLymphoma, B-Cell

Similarity Score9%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02702141Phase 1StudyDirector

A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma

Diffuse Large B-cell LymphomaDLBCLGrade 3 Follicular Lymphoma+1 more

Terminated

NCT02592876Phase 2StudyDirector

Treatment Study of Denintuzumab Mafodotin (SGN-CD19A) Plus RICE Versus RICE Alone for Diffuse Large B-Cell Lymphoma

Follicular Lymphoma, Grade 3bLymphoma, B-cellLymphoma, Follicular, Grade 3b+1 more

Terminated

All 2 trials loaded